Your browser doesn't support javascript.
loading
A computational suite for the structural and functional characterization of amyloid aggregates.
Xia, Zengjie; Wu, Yunzhao; Lam, Jeff Yui Long; Zhang, Ziwei; Burke, Melanie; Fertan, Emre; Ranasinghe, Rohan T; Hidari, Eric; Danial, John S H; Klenerman, David.
Afiliação
  • Xia Z; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
  • Wu Y; UK Dementia Research Institute, University of Cambridge, Cambridge CB2 0AH, UK.
  • Lam JYL; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
  • Zhang Z; UK Dementia Research Institute, University of Cambridge, Cambridge CB2 0AH, UK.
  • Burke M; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
  • Fertan E; UK Dementia Research Institute, University of Cambridge, Cambridge CB2 0AH, UK.
  • Ranasinghe RT; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
  • Hidari E; UK Dementia Research Institute, University of Cambridge, Cambridge CB2 0AH, UK.
  • Danial JSH; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
  • Klenerman D; UK Dementia Research Institute, University of Cambridge, Cambridge CB2 0AH, UK.
Cell Rep Methods ; 3(6): 100499, 2023 06 26.
Article em En | MEDLINE | ID: mdl-37426747
We developed the aggregate characterization toolkit (ACT), a fully automated computational suite based on existing and widely used core algorithms to measure the number, size, and permeabilizing activity of recombinant and human-derived aggregates imaged with diffraction-limited and super-resolution microscopy methods at high throughput. We have validated ACT on simulated ground-truth images of aggregates mimicking those from diffraction-limited and super-resolution microscopies and showcased its use in characterizing protein aggregates from Alzheimer's disease. ACT is developed for high-throughput batch processing of images collected from multiple samples and is available as an open-source code. Given its accuracy, speed, and accessibility, ACT is expected to be a fundamental tool in studying human and non-human amyloid intermediates, developing early disease stage diagnostics, and screening for antibodies that bind toxic and heterogeneous human amyloid aggregates.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Agregados Proteicos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Cell Rep Methods Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Agregados Proteicos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Cell Rep Methods Ano de publicação: 2023 Tipo de documento: Article